These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 296787)
1. Hepatotoxicity in the treatment of acute lymphoblastic leukaemia. Topley JM; Benson J; Squier MV; Chessells JM Med Pediatr Oncol; 1979; 7(4):393-9. PubMed ID: 296787 [TBL] [Abstract][Full Text] [Related]
2. Methotrexate hepatotoxicity in children with leukemia. McIntosh S; Davidson DL; O'Brien RT; Pearson HA J Pediatr; 1977 Jun; 90(6):1019-21. PubMed ID: 870655 [TBL] [Abstract][Full Text] [Related]
3. Liver damage in children with acute leukaemia and non-Hodgkin's lymphoma on oral maintenance chemotherapy. Parker D; Bate CM; Craft AW; Graham-Pole J; Malpas JS; Stansfeld AG Cancer Chemother Pharmacol; 1980; 4(2):121-7. PubMed ID: 6930333 [TBL] [Abstract][Full Text] [Related]
4. Testicular histology after combination chemotherapy in childhood for acute lymphoblastic leukaemia. Lendon M; Hann IM; Palmer MK; Shalet SM; Jones PH Lancet; 1978 Aug; 2(8087):439-41. PubMed ID: 79804 [TBL] [Abstract][Full Text] [Related]
5. [Evaluation of hepatic function during maintenance therapy of acute lymphoblastic leukemia remission in children]. Mancini AF; Rosito P; Vecchi V; Vivarelli F; Faldella G; De Luca M Minerva Pediatr; 1977 Nov; 29(36):2133-42. PubMed ID: 271760 [No Abstract] [Full Text] [Related]
6. Oral methotrexate is as effective as intramuscular in maintenance therapy of acute lymphoblastic leukaemia. Chessells JM; Leiper AD; Tiedemann K; Hardisty RM; Richards S Arch Dis Child; 1987 Feb; 62(2):172-6. PubMed ID: 3469936 [TBL] [Abstract][Full Text] [Related]
7. Liver histology after current intensified therapy for childhood acute lymphoblastic leukemia: microvesicular fatty change and siderosis are the main findings. Halonen P; Mattila J; Ruuska T; Salo MK; Mäkipernaa A Med Pediatr Oncol; 2003 Mar; 40(3):148-54. PubMed ID: 12518342 [TBL] [Abstract][Full Text] [Related]
8. Medical Research Council leukaemia trial--UKALL V: an attempt to reduce the immunosuppressive effects of therapy in childhood acute lymphoblastic leukemia. Report to the Council by the Working Party on Leukaemia in Childhood. Chessells JM; Durrant J; Hardy RM; Richards S J Clin Oncol; 1986 Dec; 4(12):1758-64. PubMed ID: 3537216 [TBL] [Abstract][Full Text] [Related]
9. Erythrocyte concentrations of metabolites or cumulative doses of 6-mercaptopurine and methotrexate do not predict liver changes in children treated for acute lymphoblastic leukemia. Halonen P; Mattila J; Mäkipernaa A; Ruuska T; Schmiegelow K Pediatr Blood Cancer; 2006 Jun; 46(7):762-6. PubMed ID: 16395677 [TBL] [Abstract][Full Text] [Related]
10. Enteropathy complicating maintenance therapy in acute lymphoblastic leukaemia. Lewis IJ; Mainwaring D; Martin J Arch Dis Child; 1982 Sep; 57(9):663-7. PubMed ID: 6982027 [TBL] [Abstract][Full Text] [Related]
11. The use of transient elastography and FibroTest for monitoring hepatotoxicity in patients receiving methotrexate for psoriasis. Lynch M; Higgins E; McCormick PA; Kirby B; Nolan N; Rogers S; Lally A; Vellinga A; Omar H; Collins P JAMA Dermatol; 2014 Aug; 150(8):856-62. PubMed ID: 24964792 [TBL] [Abstract][Full Text] [Related]
12. Comparison of intermittent or continuous methotrexate plus 6-mercaptopurine in regimens for standard-risk acute lymphoblastic leukemia in childhood (JCCLSG-S811). The Japanese Children's Cancer and Leukemia Study Group. Koizumi S; Fujimoto T; Takeda T; Yatabe M; Utsumi J; Mimaya J; Ninomiya T; Yanai M Cancer; 1988 Apr; 61(7):1292-300. PubMed ID: 3278798 [TBL] [Abstract][Full Text] [Related]
13. Excessive chemotherapy-related myelotoxicity in children with Down syndrome and acute lymphoblastic leukaemia. Blatt J; Albo V; Prin W; Orlando S; Wollman M Lancet; 1986 Oct; 2(8512):914. PubMed ID: 2876340 [No Abstract] [Full Text] [Related]
15. Treatment of acute lymphoblastic leukaemia. Comparison of immunotherapy (B.C.G.), intermittent methotrexate, and no therapy after a five-month intensive cytotoxic regimen ((Concord trial). Preliminary report to the Medical Research Council by the Leukaemia Committee and the Working Party on Leukaemia in Childhood. Br Med J; 1971 Oct; 4(5781):189-94. PubMed ID: 4940157 [TBL] [Abstract][Full Text] [Related]